| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/07/2002 | WO2001075066A3 Dna molecules and polypeptides of pseudomonas syringae hrp pathogenicity island and their uses |
| 02/07/2002 | WO2001075000A3 A novel polypeptide - human reverse transcription-related factor-15 and a polynucleotide sequence encoding the same |
| 02/07/2002 | WO2001074380A3 Medicament containing a tissue inhibitor of metalloproteinases-2 (timp-2) as an osteo-anabolically active substance |
| 02/07/2002 | WO2001074376A3 Cathepsin inhibitors in cancer treatment |
| 02/07/2002 | WO2001073076A3 Helicase inhibitors |
| 02/07/2002 | WO2001072119A3 Non-human animal model for growth deficiency and information processing or cognitive function defects and use thereof |
| 02/07/2002 | WO2001070243A3 A method for treating early breast cancer |
| 02/07/2002 | WO2001064937A3 Caspase-inhibitory-factor (cif) and uses thereof |
| 02/07/2002 | WO2001064238A3 Methods and compositions for regulating adipocytes |
| 02/07/2002 | WO2001062921A3 Novel human regulatory protein and polynucleotides encoding the same |
| 02/07/2002 | WO2001062911A3 Antisense and catalytically acting nucleic acid molecules targeted to grb2- related with insert domain (grid) proteins and their uses |
| 02/07/2002 | WO2001062790A3 Nuclear factor polypeptides and nucleic acids encoding same |
| 02/07/2002 | WO2001059127A3 Drug metabolizing enzymes |
| 02/07/2002 | WO2001059065A3 Novel molecules of the card-related protein family and uses thereof |
| 02/07/2002 | WO2001058470A3 Methods for enhancing the bioavailability of a drug |
| 02/07/2002 | WO2001057193A3 Protein c derivatives |
| 02/07/2002 | WO2001057087A3 High affinity immunoglobulin epsilon receptor beta-subunit-like protein and nucleic acids encoding same |
| 02/07/2002 | WO2001056959B1 A substance for the use in a dietary supplementation or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome |
| 02/07/2002 | WO2001055315A3 Nucleic acids, proteins, and antibodies |
| 02/07/2002 | WO2001055211A3 Fil-1 theta dnas and polypeptides |
| 02/07/2002 | WO2001053469A3 Phosphatases |
| 02/07/2002 | WO2001053347A3 Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses |
| 02/07/2002 | WO2001049830A3 Improved lysosomal enzymes and lysosomal enzyme activators |
| 02/07/2002 | WO2001049260A3 Y-ifn liquid-droplet aerosol and method |
| 02/07/2002 | WO2001048205A3 Murine neu sequences and methods of use therefor |
| 02/07/2002 | WO2001046218A3 Fragments of pf4 and pharmaceutical compositions containing the same |
| 02/07/2002 | WO2001044294A3 Compositions and methods for inhibiting endothelial cell proliferation |
| 02/07/2002 | WO2001042449A3 Methods for introducing genes into mammalian subjects |
| 02/07/2002 | WO2001042289A3 Tetraspan polypetides and polynucleotides encoding same |
| 02/07/2002 | WO2001036448A3 Preparation and composition of peptides useful for treatment of autoimmune and transplant related graft versus host conditions |
| 02/07/2002 | WO2001035953A3 Exercise and muscle enhancement formulations |
| 02/07/2002 | WO2001034206A3 Nucleic acid-containing complex |
| 02/07/2002 | WO2001032841A3 Method of in vitro t cell differentiation of cd34+ progenitor cells |
| 02/07/2002 | WO2001030373A8 Polypeptide composition |
| 02/07/2002 | WO2001029233A3 Chimeric immunogenic compositions and nucleic acids encoding them |
| 02/07/2002 | WO2001028539A9 Agent for treating cephalic pain |
| 02/07/2002 | WO2001018216A3 26176, a novel calpain protease and uses thereof |
| 02/07/2002 | WO2001017479B1 Methods and compositions for preventing and treating prostate disorders |
| 02/07/2002 | WO2001013900A3 Compositions for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds |
| 02/07/2002 | WO2001010425A3 Use of cgrp antagonists and cgrp release inhibitors for controlling menopausal hot flashes |
| 02/07/2002 | WO2001010382A3 Compositions and methods related to claudin-7 |
| 02/07/2002 | WO2001002587A3 Novel antifungal agents and fungicides, method for the production thereof and their use |
| 02/07/2002 | WO2000071753A3 Diagnostics and therapeutics for restenosis |
| 02/07/2002 | WO2000068376A8 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same |
| 02/07/2002 | WO2000060117A3 Prediction of risk of interstitial lung disease |
| 02/07/2002 | US20020016976 Mutant multi-substrate enzyme which accepts at least one orthogonal substrate analog, whereby catalytic activity results in combination of all or part of orthogonal substrate with other substrate of enzyme; drug screening |
| 02/07/2002 | US20020016762 Method and system for foreign exchange price procurement and automated hedging |
| 02/07/2002 | US20020016625 Drug/drug delivery systems for the prevention and treatment of vascular disease |
| 02/07/2002 | US20020016616 Electro-medical device for use with biologics |
| 02/07/2002 | US20020016449 46743 and 27417, novel human acyltransferase family members and uses therefor |
| 02/07/2002 | US20020016446 Recombinant vector and use thereof for exocellular preparation of single molecula antibodies from bacillus subtilis |
| 02/07/2002 | US20020016445 Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen |
| 02/07/2002 | US20020016443 Antiproliferative factor |
| 02/07/2002 | US20020016442 Hepatitis C inhibitor tri-peptides |
| 02/07/2002 | US20020016368 Administering to a mammal a therapeutically effective amount of a compound of sulfonamide or alkanoy or amide derivative containing hetero or aromatic rings to treat osteoporosis, osteotomy, childhood idiopathic boen loss etc. |
| 02/07/2002 | US20020016360 Method of diminishing the adverse effects of interleukin-2 |
| 02/07/2002 | US20020016321 Novel tricyclic compounds for the inhibition of the ICE/ced-3 protease family of enzymes |
| 02/07/2002 | US20020016305 Yeast genes that affect viral replication |
| 02/07/2002 | US20020016303 Genes which are differentially expressed in cardiovascular disease states, relative to their expression in normal, or non-cardiovascular disease states, and/or in response to manipulations relevant to cardiovascular disease. |
| 02/07/2002 | US20020016298 Facilitate secretion of growth hormone (GH) by the anterior pituitary. |
| 02/07/2002 | US20020016295 Keratinocyte growth factor-2 formulations |
| 02/07/2002 | US20020016294 Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties |
| 02/07/2002 | US20020016292 Pharmaceutical compositions containing cyclosporins |
| 02/07/2002 | US20020016291 Cyclic peptides as potent and selective melanocortin-4 receptor antagonists |
| 02/07/2002 | US20020016290 At least 50 weight percent of the cyclosporin present in the dispersion is of particles less than about 1 mu m, said cyclosporin being amorphous. |
| 02/07/2002 | US20020016289 Methods for treatment and prevention of helicobacter pylori infection using lactoferrin |
| 02/07/2002 | US20020016288 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells |
| 02/07/2002 | US20020016286 Simultaneous administration of human growth hormone in combination with DHEA, or their precursors, releasers, analogs, or metabolites; regenerating the human thymus to allow intrathymic transplantation |
| 02/07/2002 | US20020016283 Method of treating symptoms of hormonal variation, including hot flashes, using tachykinin receptor antagonist |
| 02/07/2002 | US20020015998 Novel G protein-coupled receptors |
| 02/07/2002 | US20020015987 Peptide for use in the treatment of alzhiemer's, inflammation, cancer and immune defects |
| 02/07/2002 | US20020015981 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 02/07/2002 | US20020015980 Neurotransmitter transporter |
| 02/07/2002 | US20020015972 Immunoglobulin; for use as diagnostic tool in immunoassays |
| 02/07/2002 | US20020015957 Detecting in a biological sample from the subject an abnormal activity or an abnormal level of at least one complement pathway associated molecule, or an abnormal cellular activity mediated by the complement pathway |
| 02/07/2002 | US20020015950 Atherosclerosis-associated genes |
| 02/07/2002 | US20020015741 Method and composition for the accelerated in vivo removal of ethanol |
| 02/07/2002 | US20020015738 Peptides; animal extracts |
| 02/07/2002 | US20020015737 Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
| 02/07/2002 | US20020015734 Mixture of protein and heat sensitive polymer |
| 02/07/2002 | US20020015725 Wound healing agents |
| 02/07/2002 | US20020015709 Administration of leptin |
| 02/07/2002 | US20020015704 Antibody, its binding portion or a probe is capable of binding to normal, benign, hyperplastic and cancerous epithelia cells and killing or ablating them; does not recognize antigens circulating in the blood |
| 02/07/2002 | US20020015703 Monoclonal antibodies or soluble immunoglobulin fusion proteins to block the development of chronic Graft-Versus-Host Disease |
| 02/07/2002 | US20020015702 Control the formation and/or maintenance of epithelial and/or mesenchymal tissue; nontoxic; may be used for hair removal |
| 02/07/2002 | US20020015701 Inhibiting properdin-induced stabilization of C3 convertase by exposure to an anti-properdin antibody |
| 02/07/2002 | US20020015698 Prophylaxis and therapy of diabetes mellitus I with the help of proteolytic enzymes |
| 02/07/2002 | US20020015693 Inducing an immune response to a T-cell independent antigen in a host, comprises administering to the host cell an interleukin-12 and T-cell independent antigen such as a carbohydrate, a lipid, a glycolipid and a carrier conjugate |
| 02/07/2002 | US20020015679 Bioconjugates of nanoparticles as radiopharmaceuticals |
| 02/07/2002 | DE10035854A1 Schlangentoxin und dessen Verwendung als Arzneimittel Snake toxin and its use as a medicament |
| 02/07/2002 | DE10035156A1 New protein complex containing complex protein from botulinum toxin, useful for oral delivery of therapeutic polypeptide or low molecular weight pharmaceutical |
| 02/07/2002 | DE10034712A1 Verbrückte Glykokonjugate Bridged glycoconjugates |
| 02/07/2002 | CA2418120A1 High affinity integrin polypeptides and uses thereof |
| 02/07/2002 | CA2417900A1 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | CA2417873A1 Secretase/sheddase with asp-ase activity on the beta-site app-cleaving enzyme (bace, asp2, memepsin 2) |
| 02/07/2002 | CA2417703A1 Methods and compositions for diagnosing and treating chromosome-18p related disorders |
| 02/07/2002 | CA2417642A1 Novel human ion channel proteins and polynucleotides encoding the same |
| 02/07/2002 | CA2417636A1 Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection |
| 02/07/2002 | CA2417612A1 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | CA2417568A1 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |